ClassID:

112259

C12N2810/855 - CPC Classification

Classification description:

Vectors comprising a targeting moiety; Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from receptors; from cell surface antigens; from cell surface determinants

Sub-classes:
Recent Application in this class:
#1
20250388929
2025-12-25

Retroviral and Lentiviral Vectors

#2
20250290041
2025-09-18

METHODS FOR MANUFACTURING ADOPTIVE CELL THERAPIES

#3
20240350605
2024-10-24

TEMPERATURE-CONTROLLABLE, RNA IMMUNOTHERAPEUTIC FOR CANCER

#4
20240093232
2024-03-21

Retroviral And Lentiviral Vectors

#5
20220145302
2022-05-12

TARGETS AND METHODS FOR TREATING EPSTEIN-BARR VIRUS MEDIATED NEURODEGENERATION

#6
20220025397
2022-01-27

LIGAND-DIRECTED TARGETING VECTORS

#7
20210348191
2021-11-11

Retroviral and lentiviral vectors

#8
20210214748
2021-07-15

VECTORS

#9
20210101962
2021-04-08

Mosaic chimeric viral vaccine particle

#10
20210040499
2021-02-11

Use of Microvesicles in the Treatment of Medical Conditions

#11
20200231942
2020-07-23

ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSID AND METHODS OF USE THEREOF

#12
20200079838
2020-03-12

Mosaic chimeric viral vaccine particle

#13
20190316153
2019-10-17

Packaging cell for making a pseudotyped lentivirus

#14
20190264227
2019-08-29

Use of microvesicles in the treatment of medical conditions

#15
20190177746
2019-06-13

Retroviral and lentiviral vectors

#16
20180179555
2018-06-28

Methods of delivering a pseudotyped lentivirus

#17
20180177892
2018-06-28

Compositions of nucleic acid-containing nanoparticles for in vivo delivery

#18
20180094046
2018-04-05

Mosaic chimeric viral vaccine particle

#19
20180066280
2018-03-08

Retroviral and lentiviral vectors

#20
20180028833
2018-02-01

Recombinant self-assembling protein comprising target-oriented peptide and use thereof

#21
20170202893
2017-07-20

ONCOLYTIC TUMOR VIRUSES AND METHODS OF USE

#22
20170121388
2017-05-04

Fusion proteins and uses thereof

#23
20170051252
2017-02-23

Methods for manufacturing adoptive cell therapies

#24
20170044504
2017-02-16

Adeno-associated virus virions with variant capsid and methods of use thereof

#25
20160355789
2016-12-08

Virion display array for profiling functions and interactions of human membrane proteins

#26
20160340692
2016-11-24

Recombinant retrovirus pseudotyped with E2 alphavirus glycoprotein

#27
20160243194
2016-08-25

Puma protein expression vector and use thereof in gene therapy

#28
20160108429
2016-04-21

-Prom mediated surface expression of avidin/streptavidin

#29
20160083462
2016-03-24

Viral vectors encoding multiple highly homologous non-viral polypeptides and the use of same

#30
20160074511
2016-03-17

Recombinant self-assembling protein comprising target-oriented peptide and use thereof

#31
20150175667
2015-06-25

Method of stimulating an immune response using a pseudotyped lentivirus

#32
20140335097
2014-11-13

Expression vectors for cell-surface expression of polypeptides comprising a transmembrane domain of glycophorin A

#33
20140242031
2014-08-28

Adeno-associated virus virions with variant capsid and methods of use thereof

#34
20140017766
2014-01-16

Targeting pseudotyped retroviral vectors

#35
20130202559
2013-08-08

Use of microvesicles in the treatment of medical conditions

#36
20120230945
2012-09-13

Targeted particles and methods of using the same

#37
20120195882
2012-08-02

Method for the production of antibodies that bind to multiple membrane spanning proteins

#38
20120164106
2012-06-28

Adeno-associated virus virions with variant capsid and methods of use thereof

#39
20120134970
2012-05-31

Viral vectors encoding multiple highly homologus non-viral polypeptides and the use of same

#40
20120076820
2012-03-29

CD40L vaccines, compositions, and methods related thereto

#41
20120070462
2012-03-22

Targeted gene delivery to dendritic cells

#42
20120039799
2012-02-16

Viral nanoparticle cell-targeted delivery platform

#43
20110213006
2011-09-01

Compositions and Methods for Treatment of Uncontrolled Cell Growth

#44
20110076304
2011-03-31

ADAPTER MOLECULE FOR THE DELIVERY OF ADENOVIRUS VECTORS

#45
20100310595
2010-12-09

Method of transfection and compositions therefor

#46
20100272746
2010-10-28

Method for the preparation of virus-like particles (VLPS) comprising heterologous multiple membrane spanning proteins

#47
20100184206
2010-07-22

Targeting pseudotyped retroviral vectors

#48
20100167377
2010-07-01

Recombinant viruses comprising the membrane-proximal domain of VSV G protein

#49
20100120140
2010-05-13

Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN

#50
20100120122
2010-05-13

Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein

#51
20100015597
2010-01-21

PRODUCTION OF BIOLOGICAL CARRIERS FOR INDUCTION OF IMMUNE RESPONSE AND INHIBITION OF VIRAL REPLICATION

#52
20090186364
2009-07-23

Method of constructing recombinant proteoliposome for diagnostic use

#53
20080305119
2008-12-11

Modified Bacteriophage Vectors and Uses Thereof

#54
20080227736
2008-09-18

Targeting Pseudotyped Retroviral Vectors

#55
20080207544
2008-08-28

Compositions And Methods For Delivery Of Agents Into Cells

#56
20080019998
2008-01-24

Targeted gene delivery for dendritic cell vaccination

#57
20070036721
2007-02-15

Methods and compositions for in vivo inflammation monitoring

#58
20060216238
2006-09-28

Compositions and methods for targeting or imaging a tissue in a vertebrate subject

#59
20060134123
2006-06-22

Methods and means for targeted gene delivery

#60
20060094030
2006-05-04

Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics

#61
20060003452
2006-01-05

Vector packaging cell line

#62
20060002893
2006-01-05

Targeted adenovirus vectors for delivery of heterologous genes

#63
20050277193
2005-12-15

Vectors and methods for gene transfer

#64
20050054104
2005-03-10

Targeted particles and methods of using the same

#65
20050003547
2005-01-06

Compositions and methods for tissue specific targeting of lentivirus vectors

#66
20050002903
2005-01-06

Gene delivery system and methods of use